Keywords: pharmos, completes, phase, iii, trials, lotemax, corp

Pharmos Completes Phase III Trials With Lotemax

Article | 23 December 1996

Print This

- Pharmos Corp has completed three Phase III trials with its ophthalmology drug Lotemax (loteprednol etabonate). Two trials were for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in